ELISPOT assay of human cells collected from mouse spleens 7 days after the last boost immunization 14 days after the initial immunization in addition to boosting on day 7 exhibited higher numbers of CD3+ T cells secreting IFN-γ and Granzyme B, and tumor growth was significantly inhibited [172]. The gene discussed is IFNG; the disease is neoplasm.